Sanofi Recalls Auvi-Q Injectors Used to Treat Anaphylaxis

Share this content:
Sanofi Recalls Auvi-Q Injectors Used to Treat Anaphylaxis
Sanofi Recalls Auvi-Q Injectors Used to Treat Anaphylaxis

THURSDAY, Oct. 29, 2015 (HealthDay News) -- All packs of Auvi-Q injectors are being recalled in the United States as some may not deliver the correct dose of epinephrine, according to a news release issued by Sanofi on Wednesday.

Sanofi said it has received 26 reports from the United States and Canada of inaccurate dosage delivery from the injectors, but none resulted in patient deaths.

The recall covers all Auvi-Q injectors, including the 0.15 mg and 0.3 mg strengths for hospitals, retailers, and consumers. The products have lot numbers 2299596 through 3037230 and expiration dates of March 2016 through December 2016.

To learn how to return the injectors and to get more information, Sanofi said consumers can call 1-866-726-6340 Monday through Friday from 8 a.m. to 8 p.m. ET, or e-mail cs@sanofi.com. The company's website has additional information. Patients with Auvi-Q injectors should immediately contact their doctor for a prescription for another epinephrine auto-injector, Sanofi said.

More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease


More in Home

CDC: Too Many Health Care Workers Not Getting Flu Vaccine

CDC: Too Many Health Care Workers Not Getting ...

Vaccination protects both workers and patients

Early Mobilization Improves Outcomes, LOS in Surgical ICUs

Early Mobilization Improves Outcomes, LOS in Surgical ICUs

Patients discharged sooner, become more functional when they leave the hospital

is free, fast, and customized just for you!

Already a member?

Sign In Now »